Qiagen N.V. (QGEN)
NYSE: QGEN · Biological Products, (No Diagnostic Substances) · filing with the SEC since 1998
Who owns Qiagen N.V.
As filed with the SECHolders of 5% or more
3
Blackrock, Inc. holds 10% of Common Stock, as its SCHEDULE 13G filed Feb 6, 2026 says.
Directors and officers
0
report now, of 0 people on the record since . Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G · filed Feb 6, 2026 · Common Stock
Wellington Management Group LLP
SCHEDULE 13G/A · filed Feb 10, 2026 · Common Stock · 10.7% in Nov 12, 2025
Massachusetts Financial Services Company
SCHEDULE 13G/A · filed Jun 5, 2026 · Common Stock · 11.6% in May 14, 2025
What QGEN reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Parse Biosciences, Inc.
A company bought · acquisition · Nov 2025 · owns, named in the 20-F filed Mar 20, 2026
GNX Data Systems Ltd.
A company bought · acquisition · May 2025 · owns, named in the 20-F filed Mar 20, 2026
45 subsidiaries in 24 countries, from the list filed with the 20-F filed Mar 20, 2026.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.